Publicité
Publicité

NUTX

NUTX logo

Nutex Health Inc. Common Stock

186.99
USD
Sponsorisé
+2.88
+1.56%
09 janv., 15:59 UTC -5
Fermé
exchange

Après-marché

185.69

-1.30
-0.70%

NUTX Rapports sur les bénéfices

Ratio de surprise positive

NUTX a dépassé 7 des 12 dernières estimations.

58%

Prochain rapport

Date du prochain rapport
25 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
$263.99M
/
$6.97
Variation implicite de Q3 25 (Revenue/ EPS)
-1.42%
/
-10.18%
Variation implicite de Q4 24 (Revenue/ EPS)
+2.47%
/
-37.32%

Nutex Health Inc. Common Stock earnings per share and revenue

On 19 nov. 2025, NUTX reported earnings of 7.76 USD per share (EPS) for Q3 25, beating the estimate of 1.11 USD, resulting in a 597.97% surprise. Revenue reached 267.80 million, compared to an expected 218.09 million, with a 22.80% difference. The market reacted with a +26.87% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analystes forecast an EPS of 6.97 USD, with revenue projected to reach 263.99 million USD, implying an baisse of -10.18% EPS, and baisse of -1.42% in Revenue from the last quarter.
FAQ
For Q3 2025, Nutex Health Inc. Common Stock reported EPS of $7.76, beating estimates by 597.97%, and revenue of $267.80M, 22.8% above expectations.
The stock price moved up 26.87%, changed from $112.19 before the earnings release to $142.34 the day after.
The next earning report is scheduled for 25 mars 2026.
Based on 5 analystes, Nutex Health Inc. Common Stock is expected to report EPS of $6.97 and revenue of $263.99M for Q4 2025.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité